- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05091710
Haiti Community Health Workers (CHW) Adaptation
Pilot Trial of a Community Health Worker Intervention to Improve Heart Failure Care in Rural Haiti
Evidence-based interventions to improve linkage and outcomes for heart failure (HF) patients requires input from stakeholders: patients, community health workers (CHWs), healthcare staff, and health system administrators.
In this research the investigators will assess a CHW intervention designed to improve linkage to care for HF patients. This intervention was systematically adapted for use in rural Haiti in a prior study using the Assessment, Decisions, Administration, Production, Topical Experts, Integration, Training staff, Testing (ADAPT-ITT) framework. The ADAPT-ITT framework provides 8 sequential phases to adapt interventions and programs to new target audiences. It has been applied successfully to the adaptation of several interventions for HIV among under-resourced communities leading to randomized clinical trials. With the first 6 steps of the ADAPT-ITT framework completed in a prior study, this protocol outlines the training and testing of the adapted CHW intervention.
In addition to assessing the feasibility, appropriateness, and acceptability of the adapted intervention through participants' feedback, the investigators will assess its efficacy in improving HF outcomes. The proposed intervention is targeted at both the patient domain - through improved peer support - and health system domain - by improving health system navigation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a clinical trial involving the training of 6 CHWs in a linkage-to-care intervention and the testing of the intervention on 30 HF patients. In a prior study, the ADAPT-ITT framework was used to adapt a CHW-based intervention for post-discharge HF patients in Haiti. This study represents the last two phases of the ADAPT-ITT framework: Training and Testing.
The study population will include adult HF patients (> 18 years of age), hospitalized for more than 48 hours, discharged from Hôpital-Universitaire de Mirebalais (HUM), without a prior clinic visit, living in Mirebalais Commune. Patients will be recruited for study participation shortly before discharge. A comparison group of 30 HF patients will be recruited and will not participate in the follow up care intervention. Those patients will be retrospectively identified from the medical record. The comparison group and will not receive any intervention. Six experienced CHWs will be trained to conduct the linkage to care intervention.
The intervention will include study visits in the form of home visits and phone calls performed by CHWs during which they will remind patients about upcoming visits, ensure patient has sufficient medications, review medication schedule and provide education as needed.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gene F Kwan, MD MPH
- Phone Number: 617-638-8786
- Email: gene.kwan@bmc.org
Study Locations
-
-
-
Mirebalais, Haiti
- Recruiting
- Zanmi Lasante/Hôpital Universitaire de Mirebalais
-
Contact:
- Darius Fenelon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for patient participant:
- Adult HF patients
- Hospitalized >48 hours at Hôpital-Universitaire de Mirebalais (HUM)
- Anticipated discharge from HUM within 1-3 days
- Living in Mirebalais Commune, Haiti Inclusion criteria for historical patient reference group
- Adult HF patients
- Hospitalized >48 hours at HUM
- Discharged from HUM within the 12 months preceding the intervention
- Living in Mirebalais Commune
Exclusion Criteria for patient participant and historical patient reference group:
- None
Inclusion Criteria for CHW
- Adult
- Provide inpatient or outpatient care to HF patients
- Working in in Mirebalais
Exclusion Criteria for CHW
- None
Inclusion criteria for healthcare staff (provider/administrator)
- Hospital leadership involved in supervision of clinical care programs (i.e. Chief Executive Officer, Chief Medical Officer, Chief Operations Officer, Chief Nursing Officer, etc.)
- Leaders of the Community Health Department - including the nurse Director of Community Health, and Community Health Worker Supervisors.
- Healthcare providers at HUM involved in the care of patients with heart failure (i.e. internal medicine physicians, inpatient hospital nurses, outpatient clinic physicians, outpatient clinic nurses, etc.)
Exclusion criteria for healthcare staff (provider/administrator)
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Follow up care program for HF patients
Discharged HF patients in rural Haiti will be receive a follow-up care program delivered by trained community health workers (CHWs).
|
The intervention will consist of follow up phone calls and visits during which the CHWs will remind patients about upcoming visits, ensure patient has sufficient medications, review medication schedule and provide education as needed.
|
Other: Standard of care
Historical reference group who received standard of care for HF identified prior to CHW training.
|
SOC after discharge for HF is to notify patients of a follow-up visit at the hospital/clinic - about 7 days after discharge and provide patients about 30 days of medications at discharge.
If a patient does not return for a follow-up appointment, there are no systems to track this missed visit, or to trigger active attempts to contact patients.
For patients who come back to their scheduled 7-day visit, there is generally a 14-day visit followed by a 28-day visit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability of HF follow up program to patients
Time Frame: 90 days
|
Acceptability of the HF follow up program to patients will be assessed using a 5-point Likert scale response to the question "Was it acceptable to have a CHW come to your home to educate you in your heart failure care and encourage clinic follow-up?"
where 1=not acceptable, 5=very acceptable.
|
90 days
|
Acceptability of HF follow up program to Community Health Workers (CHWs)
Time Frame: 12 months
|
Acceptability of the HF follow up program to CHWs will be assessed using a 5-point Likert scale response to the question "Was it acceptable to have a CHW come to your home to educate you in your heart failure care and encourage clinic follow-up?"
where 1=not acceptable, 5=very acceptable.
|
12 months
|
Acceptability of HF follow up program to nurses/doctors
Time Frame: 12 months
|
Acceptability of the HF follow up program to nurses/doctors will be assessed using a 5-point Likert scale response to the question "Was it acceptable to have a CHW come to your home to educate you in your heart failure care and encourage clinic follow-up?"
where 1=not acceptable, 5=very acceptable.
|
12 months
|
Appropriateness of HF follow up program to patients
Time Frame: 90 days
|
Appropriateness of HF follow up program to patients will be assessed using a 5-point Likert scale response to the question "Were you satisfied with the CHWs interactions with you?" where 1=not acceptable, 5=very acceptable.
|
90 days
|
Appropriateness of HF follow up program to CHWs
Time Frame: 12 months
|
Appropriateness of HF follow up program to CHWs will be assessed using a 5-point Likert scale response to the question "Were you satisfied with the CHWs interactions with you?" where 1=not acceptable, 5=very acceptable.
|
12 months
|
Appropriateness of HF follow up program to nurses/doctors
Time Frame: 12 months
|
Appropriateness of HF follow up program to nurses/doctors will be assessed using a 5-point Likert scale response to the question "Were you satisfied with the CHWs interactions with you?" where 1=not acceptable, 5=very acceptable.
|
12 months
|
Feasibility of HF follow up program to patients
Time Frame: 90 days
|
Feasibility of HF follow up program to patients will be assessed by the percent of invited eligible patients who consent to participate.
The higher the percentage of consenting patients, the more feasible the program.
|
90 days
|
Feasibility of HF follow up program to CHWs
Time Frame: 90 days
|
Feasibility of HF follow up program to CHWs will be assessed by the percent of invited CHWs who complete the training.
The higher the percentage, the more feasible the program.
|
90 days
|
Fidelity of HF follow up program
Time Frame: 90 days
|
Fidelity of HF follow up program will be assessed by the percent of home visit checklist items completed by CHWs.
The higher the percentage, the greater the fidelity.
|
90 days
|
HF follow up program intervention components delivered
Time Frame: 90 days
|
Assessed by the number of interventions delivered based abstracted from the home visit checklist completed by the CHWs.
|
90 days
|
Completion of scheduled visits
Time Frame: 90 days
|
Assessed by the percent of scheduled visits that were completed from the CHW records.
|
90 days
|
Percent of visits with all home visit checklist items completed
Time Frame: 90 days
|
Assessed by dividing the number of visits with all home visit checklist items completed by the total number of visits.
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Linkage of HF patients
Time Frame: 30 days
|
Percent of patients that complete 30 day follow up visit
|
30 days
|
Retention of HF patients
Time Frame: 90 days
|
Percent of patients that complete 90 day follow up visit
|
90 days
|
Hospital readmission rate
Time Frame: 90 days
|
Percent of patients that are readmitted to the hospital abstracted from the medical charts
|
90 days
|
Patient symptoms based on the New York Heart Association (NYHA) Classification
Time Frame: 90 days
|
A New York Heart Association (NHYA) class from 1 to 4 will be assigned to each patient. The higher the classification the more serious the symptoms NYHA Classification - The Stages of Heart Failure: Class 1 - No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc. Class 2 - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. Class 3 - Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m).Comfortable only at rest. Class 4 - Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients. |
90 days
|
Patient quality of life assessed European Quality of Life 5D (EuroQol 5D)
Time Frame: 30 days, 90 days
|
Quality of life of patients will be assessed with the European Quality of Life 5D (EuroQol 5D) level.
ThevEuropean Quality (EQ)-5D descriptive system is a preference-based Health-related quality of life (HRQL) measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
The answers given to EQ-5D permit to find 243 unique health states or can be converted into EQ-5D index an utility scores anchored at 0 for death and 1 for perfect health.
The EQ-5D questionnaire also includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
|
30 days, 90 days
|
Symptoms and quality of life based on the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Time Frame: 30 days, 90 days
|
The KCCQ will be used to assess symptoms, physical and social limitations, and quality of life in HF patients.
Scores are scaled from 0 to 100 and will be summarized in 25-point ranges, where scores represent health status as follows: 0 to 24: very poor to poor; 25 to 49: poor to fair; 50 to 74: fair to good; and 75 to 100: good to excellent.
|
30 days, 90 days
|
Mortality rate in HF patients
Time Frame: 90 days
|
The number of HF patients who die within 90 days following discharge will be calculated.
|
90 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Gene F Kwan, MD MPH, Boston Medical Center, Cardiovascular Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-41758
- 1K23HL140133-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
Clinical Trials on HF follow up care
-
Istanbul University - Cerrahpasa (IUC)CompletedInfertility | Psychological Distress | Infertility, Female | Depression, Anxiety | Nurse's RoleTurkey
-
Ottawa Hospital Research InstituteActive, not recruiting
-
Tarik Wasfie, MDCompletedTraumatic Subdural HematomaUnited States
-
Queen's University, BelfastBelfast Health and Social Care Trust; Southern Health and Social Care TrustWithdrawnCataract | Age-related Cataract
-
Pontificia Universidad Catolica de ChileUniversity of Technology, SydneyCompletedCardiovascular Diseases | Hypertension | Type 2 Diabetes Mellitus | Dyslipidemias | Medication Adherence | Drug UseChile
-
Cairo UniversityUnknown
-
Helse Stavanger HFThe Research Council of Norway; Helse Vest; Norwegian Nurses Organisation; Bergen... and other collaboratorsActive, not recruitingDiabetic Foot | Foot UlcerNorway
-
Turkiye Yuksek Ihtisas Education and Research HospitalCompletedCOVID-19 | Intensive Care Unit | Morality | Obstetric Anesthesia ProblemsTurkey
-
Hospital Universitario ArabaLinde Health Care; Spain:Health Department. Basque Government.Completed
-
Women's College HospitalCanadian Institutes of Health Research (CIHR)CompletedUse of Mobile App Home Monitoring After Ambulatory SurgeryCanada